Latest oppositions filed by Merck Serono S.a.

This table presents recent patent oppositions filed by Merck Serono S.a. against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP2292252Unitary Combination Of Fsh And HcgFERRING B.V.May 5, 2020
EP3045471Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-SialylationFERRING B.V.Dec 22, 2017

The following table provides an overview of the latest patents of Merck Serono S.a. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP2164877Dec 13, 2017The Puro-Dhfr Quadrifunctional Marker And Its Use In Protein Production1